MetaADEDB 2.0 @ LMMD
Glycerol
(PEDCQBHIVMGVHV-UHFFFAOYSA-N)
Structure
SMILES
OCC(CO)O
Type(s)
Approved; Investigational
ATC code(s)
A06AG04; A06AX01
Molecular Formula:
C3H8O3
Molecular Weight:
92.094
Log P:
-1.6681
Hydrogen Bond Acceptor:
3
Hydrogen Bond Donor:
3
TPSA:
60.69
CAS Number(s):
56-81-5; 8043-29-6; 25618-55-7; 30918-77-5; 82425-96-5; 98292-00-3
Synonym(s)
1.
Glycerol
2.
Glycerin
3.
1,2,3-Trihydroxypropane
4.
Glycerine
External Link(s)
MeSHD005990
PubChem Compound753
ChEBI17522
17754
CHEMBLCHEMBL692
DrugBankDB09462
DrugCentral1316
IUPHAR/BPS Guide to PHARMACOLOGY5195
KEGGcpd:C00116
dr:D00028
ZINC895048
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1Drug ineffectiveFAERS: 2US FAERS
2ErythemaFAERS: 1SIDER
US FAERS
3PruritusFAERS: 1SIDER
US FAERS
4Quality of life decreasedFAERS: 1US FAERS
5Skin tightnessFAERS: 1US FAERS
6UrticariaFAERS: 1SIDER
US FAERS
7Abdominal PainCanada Vigilance: 1Canada Vigilance
OFFSIDES
SIDER
8Abdominal discomfortSIDER
9Abdominal rigidityOFFSIDES
10Abdominal tendernessOFFSIDES
11AcidosisOFFSIDES
12Acute bronchitisOFFSIDES
13Acute kidney injury

View details

1134612
1324513
1751788
2087497
4644892
6822758
10677590
11485932
12021577
16820301
22021999
22613216
30974099
 		CTD
14Acute respiratory failureOFFSIDES
15Alanine Aminotransferase IncreasedOFFSIDES
16Altered state of consciousnessOFFSIDES
17Ammonia increasedSIDER
18Anal FissureOFFSIDES
19Anal FistulaOFFSIDES
20Anal abscessOFFSIDES
21Anaphylactic shockSIDER
22Anaplastic astrocytomaOFFSIDES
23Angina PectorisCanada Vigilance: 1Canada Vigilance
24AngioedemaSIDER
25AnorexiaOFFSIDES
26Anticholinergic SyndromeOFFSIDES
27Anuria1751788CTD
OFFSIDES
28ApathyOFFSIDES
29AscitesOFFSIDES
30Aseptic MeningitisOFFSIDES
31Aspiration PneumoniaOFFSIDES
32AstheniaSIDER
33AsthmaOFFSIDES
SIDER
34Atrial FlutterOFFSIDES
35Bilirubin conjugated increasedOFFSIDES
36Blood albumin decreasedOFFSIDES
37Blood alkaline phosphatase increasedOFFSIDES
38Blood creatinine increasedOFFSIDES
39Blood fibrinogen increasedOFFSIDES
40Blood lactate dehydrogenase increasedOFFSIDES
41Blood magnesium decreasedOFFSIDES
42Blood sodium increasedOFFSIDES
43Blood sodiumOFFSIDES
44Blood urea increasedOFFSIDES
45BradycardiaOFFSIDES
SIDER
46Brain DeathOFFSIDES
47Brain natriuretic peptide increasedOFFSIDES
48Brain stem syndromeOFFSIDES
49Cerebrovascular operationOFFSIDES
50Choking sensationOFFSIDES
51CholangiolitisOFFSIDES
52ConjunctivitisSIDER
53CyanosisSIDER
54DehydrationOFFSIDES
55Dental cleaningOFFSIDES
56Dental examinationOFFSIDES
57Depressed Level of ConsciousnessOFFSIDES
58DermatitisSIDER
59Device malfunctionOFFSIDES
60Diabetes InsipidusOFFSIDES
61Disease ProgressionOFFSIDES
62Disseminated Intravascular CoagulationOFFSIDES
63DizzinessSIDER
64DrowsinessOFFSIDES
65DyslaliaOFFSIDES
66DyspepsiaSIDER
67Enterococcal infectionOFFSIDES
68EpiglottitisOFFSIDES
69Eye irritationCanada Vigilance: 1Canada Vigilance
70FatigueSIDER
71FlatulenceSIDER
72Fluid intake restrictionOFFSIDES
73FlushingSIDER
74Gamma-Glutamyltransferase IncreasedOFFSIDES
75Gastrointestinal PainSIDER
76General physical health deteriorationOFFSIDES
77Glioblastoma MultiformeOFFSIDES
78GlioblastomaOFFSIDES
79GranulocytosisOFFSIDES
80Gum neoplasm malignant stage unspecifiedOFFSIDES
81HaematotoxicityOFFSIDES
82HeadacheSIDER
83Heat Stroke16878031CTD
84HemiplegiaOFFSIDES
85HepatitisOFFSIDES
86Human herpes virus 6 serology positiveOFFSIDES
87HydrocephalusOFFSIDES
88Hyperkalemia11046231CTD
89HyperventilationOFFSIDES
90Hyponatremia3919450CTD
91HypotensionSIDER
92Immunosuppressant drug levelOFFSIDES
93Incorrect route of product administrationCanada Vigilance: 1Canada Vigilance
94InfectionOFFSIDES
95Infusion site mobility decreasedOFFSIDES
96Intestinal ObstructionOFFSIDES
97Intestinal PerforationOFFSIDES
98Intracranial AneurysmOFFSIDES
99Kidney Diseases19452295
19484701
26562095		CTD
100LacrimationSIDER
101Large intestine perforationOFFSIDES
102Leukopenia neonatalOFFSIDES
103LipaseOFFSIDES
104Local reactionSIDER
105Lung AbscessOFFSIDES
106Lung infection pseudomonalOFFSIDES
107Lymphocyte count decreasedOFFSIDES
108Lymphocyte stimulation test positiveOFFSIDES
109Malignant neoplasm progressionOFFSIDES
110MalnutritionSIDER
111MastoiditisOFFSIDES
112MetaplasiaOFFSIDES
113MonoparesisOFFSIDES
114Multiple MyelomaOFFSIDES
115Muscle WeaknessOFFSIDES
116Musculoskeletal stiffnessOFFSIDES
117Myocardial Ischemia531484CTD
118Myoglobinuria10362817CTD
119NauseaOFFSIDES
SIDER
120Necrosis20299303CTD
121Nephritis16272714CTD
122Nephrogenic Diabetes InsipidusOFFSIDES
123Nephrotic SyndromeOFFSIDES
124Neutrophil count decreasedOFFSIDES
125OliguriaOFFSIDES
126Oral mucosal exfoliationOFFSIDES
127Oropharyngeal discomfortOFFSIDES
128PainSIDER
129PallorSIDER
130Perianal abscessOFFSIDES
131Pneumocystis jiroveci pneumoniaOFFSIDES
132Postrenal failureOFFSIDES
133Protein total decreasedOFFSIDES
134Prothrombin level decreasedOFFSIDES
135Pulmonary InfarctionOFFSIDES
136Pulmonary congestionOFFSIDES
137Renal Insufficiency16272714CTD
138Respiratory FailureOFFSIDES
139Rhabdomyolysis22021999
27329933		CTD
OFFSIDES
140RhinitisSIDER
141Ruptured cerebral aneurysmOFFSIDES
142Septic ShockOFFSIDES
143ShockSIDER
144Skin necrosisOFFSIDES
145SneezingSIDER
146SubileusOFFSIDES
147Superficial ThrombophlebitisOFFSIDES
148Superior Vena Cava SyndromeOFFSIDES
149SwellingSIDER
150SyncopeSIDER
151Tachycardia, Ventricular11046231CTD
152TachycardiaSIDER
153Tracheal StenosisOFFSIDES
154VomitingSIDER
155Vulvovaginal discomfortOFFSIDES
156Vulvovaginal mycotic infectionOFFSIDES
157Water IntoxicationOFFSIDES
158WheezingSIDER
159nervous system disorderSIDER
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120239

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.